340 related articles for article (PubMed ID: 28427966)
21. Risk factors for heparin-induced thrombocytopenia: Focus on Fcγ receptors.
Rollin J; Pouplard C; Gruel Y
Thromb Haemost; 2016 Oct; 116(5):799-805. PubMed ID: 27358188
[TBL] [Abstract][Full Text] [Related]
22. Novel Strategy to Combat the Procoagulant Phenotype in Heparin-Induced Thrombocytopenia Using 12-LOX Inhibition.
Renna SA; Zhao X; Kunapuli SP; Ma P; Holinstat M; Boxer MB; Maloney DJ; Michael JV; McKenzie SE
Arterioscler Thromb Vasc Biol; 2023 Oct; 43(10):1808-1817. PubMed ID: 37345522
[TBL] [Abstract][Full Text] [Related]
23. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
[TBL] [Abstract][Full Text] [Related]
24. Heparin-induced thrombocytopenia: pathophysiology and new treatment options.
Harenberg J; Jörg I; Fenyvesi T
Pathophysiol Haemost Thromb; 2002; 32(5-6):289-94. PubMed ID: 13679659
[TBL] [Abstract][Full Text] [Related]
25. Rapid and durable response to intravenous immunoglobulin in delayed heparin-induced thrombocytopenia: a case report.
Lei BZ; Shatzel JJ; Sendowski M
Transfusion; 2017 Apr; 57(4):919-923. PubMed ID: 27943368
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic plasma exchange and intravenous immune globulin in the treatment of heparin-induced thrombocytopenia: A systematic review.
Onuoha C; Barton KD; Wong ECC; Raval JS; Rollins-Raval MA; Ipe TS; Kiss JE; Boral LI; Adamksi J; Zantek ND; Onwuemene OA
Transfusion; 2020 Nov; 60(11):2714-2736. PubMed ID: 32812222
[TBL] [Abstract][Full Text] [Related]
27. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
28. Fondaparinux cross-reactivity in heparin-induced thrombocytopenia successfully treated with high-dose intravenous immunoglobulin and rivaroxaban.
Manji F; Warkentin TE; Sheppard JI; Lee A
Platelets; 2020; 31(1):124-127. PubMed ID: 31397594
[TBL] [Abstract][Full Text] [Related]
29. An update on heparin-induced thrombocytopenia: diagnosis and management.
Bakchoul T
Expert Opin Drug Saf; 2016 Jun; 15(6):787-97. PubMed ID: 26966871
[TBL] [Abstract][Full Text] [Related]
30. New concepts in heparin-induced thrombocytopenia: diagnosis and management.
Spinler SA
J Thromb Thrombolysis; 2006 Feb; 21(1):17-21. PubMed ID: 16475037
[TBL] [Abstract][Full Text] [Related]
31. Novel Knowledge about Molecular Mechanisms of Heparin-Induced Thrombocytopenia Type II and Treatment Targets.
Mongirdienė A; Liuizė A; Kašauskas A
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175923
[TBL] [Abstract][Full Text] [Related]
32. [Clinical study of heparin-induced thrombocytopenia].
Wang JH; Wang CY; Xie R; Che DH; Jia RC; Ju W; Miao MJ; Wang H; Jiang Y; Tong DX
Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):115-7. PubMed ID: 21429379
[TBL] [Abstract][Full Text] [Related]
33. Heparin-induced thrombocytopenia in intensive care patients.
Selleng K; Warkentin TE; Greinacher A
Crit Care Med; 2007 Apr; 35(4):1165-76. PubMed ID: 17334253
[TBL] [Abstract][Full Text] [Related]
34. New developments in diagnosis and treatment of heparin-induced thrombocytopenia.
Lubenow N
Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):407-12. PubMed ID: 15692252
[TBL] [Abstract][Full Text] [Related]
35. Reducing thrombotic complications in the perioperative setting: an update on heparin-induced thrombocytopenia.
Levy JH; Tanaka KA; Hursting MJ
Anesth Analg; 2007 Sep; 105(3):570-82. PubMed ID: 17717208
[TBL] [Abstract][Full Text] [Related]
36. [Heparin-induced thrombocytopenia (HIT): pathogenesis, laboratory test, and treatment].
Matsuo T; Wanaka K; Asada R
Rinsho Byori; 2005 Jul; 53(7):622-9. PubMed ID: 16104531
[TBL] [Abstract][Full Text] [Related]
37. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
38. The approach to heparin-induced thrombocytopenia.
Linkins LA; Warkentin TE
Semin Respir Crit Care Med; 2008 Feb; 29(1):66-74. PubMed ID: 18302088
[TBL] [Abstract][Full Text] [Related]
39. [Heparin-induced thrombocytopenia. New therapeutical options].
Seculini Patiño CE; Tabares AH
Medicina (B Aires); 2016; 76(4):230-4. PubMed ID: 27576282
[TBL] [Abstract][Full Text] [Related]
40. High-dose intravenous gamma-globulins for heparin-induced thrombocytopenia: a prompt response.
Winder A; Shoenfeld Y; Hochman R; Keren G; Levy Y; Eldor A
J Clin Immunol; 1998 Sep; 18(5):330-4. PubMed ID: 9793825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
